(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5(Date:10/8/2008)... /- Vical Incorporated (Nasdaq: VICL...new nonclinical data,demonstrating that the compan...e in DNA- and protein-based infectious disease vac...Rolland, Pharm.D., Ph.D., Vical,s,Senior Vice Pres...a today,Wednesday, October 8, at the World Vaccin...
(Date:10/7/2008)... /- McLaren Health Care and its Great...world,s leading medical,minds to share the latest ...ointestinal cancer treatments. The October 11th sy... by McLaren,s Sukamal Saha, M.D., an,award-winning...apping for,colorectal cancer has gained worldwide ...
(Date:10/7/2008)...al Presented at the Osteoarthritis Research Societ..., N.J., Oct. 7 /- Ferring Pharmaceuti...X Trial of Osteoarthritis of the,Knee, showing tha...re,non-avian high molecular weight form of intra-a...ntra-articular saline (IA-saline) for the relief,o...
(Date:10/7/2008).../- CEL-SCI Corporation,(NYS... a Material Transfer,Agreement (MTA) with the Nati...and the laboratory of Dr. Francesco M. Marincola, ...s to the tumor microenvironment,caused by CEL-SCI,...f of,the Infectious Disease and Immunogentics Sect...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call 9642 1STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call 9642 2STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call 9642 3OMI Medical Imaging Inc and Affiliated Companies File Chapter 11 Reorganization 9640 1OMI Medical Imaging Inc and Affiliated Companies File Chapter 11 Reorganization 9640 2Bristol Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31 2616 1RSB Spine LLC Announces First Implantation of the InterPlate 28TM 29 L for the Lumbar Spine 2614 1RSB Spine LLC Announces First Implantation of the InterPlate 28TM 29 L for the Lumbar Spine 2614 2... 08, 2007 /PRNewswire-FirstCall/ -- Vanda,Pharmace...rector of,the Henry Ford Sleep Disorders and Resea...esentation on recent Phase III clinical,trial resu...T2),receptor agonist, at SLEEP 2007, the 21st annu...cieties, (APSS). , The Vanda presentation will tak...
...RE)--Jun 7, 2007 - ApoCell, Inc. presented the,res...iversity of,Chicago and ApoCell at the 2007 annual...ogy (ASCO) held in Chicago in early June.,The stud...iomarker,assay technology provides reliable predic...the benefit of treating aggressive head,and neck c...
Other Medicine Technology:Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the,Annual Meeting of the Associated Professional Sleep Societies 2ApoCell's Cancer Predictive Index Helps Oncologists Select the Most,Effective Targeted Drug Therapy 2... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: